News for Novamind Inc. (NVMDF)

Following recent fourth quarter financial results, Numinus Wellness Inc. (OTC: NUMIF) CEO Payton Nyquvest gave his views on Numinus’ first quarterly earnings report following the consolidation of Novamind Inc., and the roadmap for profitability now t

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results late Monday for the three and twelve months ended August 31, 2022.

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and...

Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness  Corp., has entered into a joint venture agreement  with  Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience and  more than 30.000 patients treated, specializing in multidisciplinary medical specialties.

DelveInsight’s post-traumatic stress disorder pipeline report depicts a robust space with 25+ active players working to develop 25+ pipeline therapies for...

Numinus has the potential to actively participate in a wave of consolidation that will roll through the psychedelics sector. See my take on this stock here.

/PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to...

Zinger Brief Dr. Dartiu da Silveira is a renowned Brazilian psychiatrist and a pioneer in psychedelics scientific research. Dr. Silveira will collaborate with Bienstar as a scientific advisor. The advisor will focus on ibogaine assisted therapies protocols, medical education programs and clinical research development.

Zinger Brief The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million. Ketamine and ibogaine substances are regulated for medical use in Brazil.

Revenues grew 32% year-over-year to $0.74 million for the quarter Clinic network revenues grew 59.5% from the same quarter last year and 7.5% compared to prior...

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.

The psychedelics legislative landscape continues to move forward with Hazel Park, Michigan enacting decriminalization measures for naturally-produced psychedeli...

On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received full approval in both U...

Toronto, Ontario-- Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... | November 4, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...